You are here
Nobivac Tricat Trio is the UK’s leading core feline vaccine. It provides broad immunisation with live attenuated FCV, FHV and FPLV. An extended minimum duration of immunity againt panleucopaenia for up to 3 years from vaccination with Nobivac Tricat Trio means that on intervening years Nobivac Ducat, a bivalent vaccine against the two viral causes of FURTD, may be administered as the booster vaccine.
Lyophilisate: Off-white lyophilisate with solvent for suspension for injection
Live vaccine containing per dose of 1 ml reconstituted vaccine:
- live attenuated feline calicivirus, strain F9: ≥104.6 PFU;
- live attenuated feline herpes virus type 1, strain G2620A: ≥105.2 PFU;
- live attenuated feline panleucopenia virus, strain MW-1: ≥104.3 CCID5
Indications for use
Nobivac Tricat Trio is indicated for active immunisation of cats to reduce clinical signs caused by an infection with feline calicivirus (FCV) and feline herpes virus type 1 (FHV1) and to prevent clinical signs, virus excretion and leucopenia caused by feline panleucopenia virus (FPLV).
APET-plastic tray containing 10 or 50 single dose vials. The diluent may be packed together with the vaccine or separately.
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018